Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

Across the recent three months, 7 analysts have shared their insights on Absci ABSI, expressing a variety of opinions spanning from bullish to bearish.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $7.14, a high estimate of $10.00, and a low estimate of $5.00. This current average represents a 2.06% decrease from the previous average price target of $7.29.

Decoding Analyst Ratings: A Detailed Look

The standing of Absci among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Absci. This offers insight into analysts' perspectives on the current state of the company.
• Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Absci compared to the broader market.
• Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Absci's stock. This examination reveals shifts in analysts' expectations over time.

To gain a panoramic view of Absci's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.

Stay up to date on Absci analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

Get to Know Absci Better

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Unraveling the Financial Story of Absci

Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.

Positive Revenue Trend: Examining Absci's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 128.63% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.

Net Margin: Absci's net margin excels beyond industry benchmarks, reaching -1610.7%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): Absci's ROE excels beyond industry benchmarks, reaching -12.96%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Absci's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -11.17%, the company may face hurdles in achieving optimal financial performance.

Debt Management: Absci's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.06.

What Are Analyst Ratings?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.